Rare diseases
Investigational molecules
Locations
1000 Winter Street Suite 3300, 02451-1230, United States
Clinical research is centered on advanced ovarian cancer, including stage III and stage IV disease, with attention to non-mucinous epithelial ovarian cancer and fallopian and peritoneal cancers. The studies also focus on tumors with HRD features and treatment after response to platinum-based chemotherapy.
The portfolio includes work in both newly treated and recurrent settings, with emphasis on disease control in advanced ovarian malignancies.
Tesaro Inc. runs clinical trials in conditions such as Ovarian cancer, Homologous recombination deficiency positive advanced ovarian cancer, Ovarian cancer stage IV, Ovarian cancer stage III, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Spain
BelgiumBelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
